Premium
Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin–rifampicin combination for hidradenitis suppurativa?
Author(s) -
Albrecht J.,
Barbaric J.,
Nast A.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.17422
Subject(s) - hidradenitis suppurativa , rifampicin , clindamycin , medicine , dermatology , antibiotics , microbiology and biotechnology , pathology , biology , tuberculosis , disease
Linked Article: Albrecht et al. Br J Dermatol 2019; 180 :749–755.